Dr. Matilde Venero, MD

Dr. Venero practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Venero's NPI, 1295712586, was assigned on December 28, 2005. Dr. Venero graduated from Lisandro Alvarado Western University School of Medicine in 1995. Dr. Venero's New Mexico license number on file is MD2005-0065.

Dr. Venero's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Venero's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Venero to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venero practices. Vendor and product names are available with a free account.

Family medicine is Dr. Venero's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Venero is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Venero's licenses on file in 3 states: New Mexico, California and Florida.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, ankle or foot injury, conjunctivitis, contact dermatitis, eyelid inflammation and gastroenteritis among the conditions Dr. Venero treats.

CMS data shows 406 Medicare services from Dr. Venero across 10 procedure codes in 2024, for 283 Medicare patients. Medicare paid $21,585 for them. Every service was in an office.

CMS counts 283 Medicare patients who saw Dr. Venero in 2024. The largest group is 65 to 74, with 116 patients. 64% of them have high blood pressure, and 61% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Venero's median patient age at 47, with 65% women.

In 2024, Dr. Venero wrote 457 Medicare Part D claims for 321 patients. 83% of them were for generic drugs. CMS names the drug for 363 of them, across 12 drugs with 11 or more claims each, at $4,050 in total drug cost. In 2023, CMS named 161 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Venero for performance year 2024, reported as part of a group. Dr. Venero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Venero as offering telehealth.

Dr. Venero graduated from Lisandro Alvarado Western University School of Medicine in 1995.

Dr. Venero is in network with 3 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.